#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16342	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2054	788.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1425	1425	C	915	C	852	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29622	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3551	831.3	0	.	n	.	0	T695C	SNP	695	695	T	993	993	C	936	C,T,A	877,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29622	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3551	831.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1635	1635	A	973	A,G	924,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29622	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3551	831.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2269	2269	C	947	C	887	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29622	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3551	831.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2343	2343	A	958	A	891	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29622	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3551	831.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2895	2895	C	889	C	841	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2118	folP	855	855	100.0	folP.l6.c4.ctg.1	1538	137.0	1	SNP	p	R229S	0	.	.	685	687	CGC	965	967	CGC	208;206;206	C,T;G;C	192,2;193;191	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5796	gyrA	2751	2751	99.89	gyrA.l15.c30.ctg.1	3439	167.9	1	SNP	p	S91F	0	.	.	271	273	TCC	602	604	TCC	210;207;206	T;C;C,A	191;189;189,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5796	gyrA	2751	2751	99.89	gyrA.l15.c30.ctg.1	3439	167.9	1	SNP	p	D95G	0	.	.	283	285	GAC	614	616	GAC	205;208;207	G;A;C	192;192;192	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5796	gyrA	2751	2751	99.89	gyrA.l15.c30.ctg.1	3439	167.9	1	SNP	p	D95N	0	.	.	283	285	GAC	614	616	GAC	205;208;207	G;A;C	192;192;192	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1842	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1276	143.6	0	.	p	.	0	S32W	NONSYN	94	96	TCG	435	437	TGG	217;218;214	T;G;G,T	198;202;195,1	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1842	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1276	143.6	0	.	p	.	0	D79N	NONSYN	235	237	GAT	576	578	AAT	230;229;229	A;A;T	219;216;213	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1842	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1276	143.6	1	SNP	p	G45D	0	.	.	133	135	GGC	474	476	GGC	238;236;237	G;G;C	223;220;223	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	894	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1087	82.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5784	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3132	184.1	1	SNP	p	D86N	0	.	.	256	258	GAC	707	709	GAC	239;234;232	G;A;C	218;213;214	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5784	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3132	184.1	1	SNP	p	S88P	0	.	.	262	264	TCC	713	715	TCC	230;236;237	T;C;C	216;220;222	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4646	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2579	179.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1483	1485	GGC	245;244;242	G;G;C	235;234;230	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2292	187.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1205	1207	GCA	239;239;240	G;C,T;A	225;224,1;228	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2292	187.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1208	1210	ATC	242;243;245	A;T;C,T	227;228;230,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2292	187.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1220	1222	GTG	240;239;242	G;T;G	228;225;231	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2292	187.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1220	1222	GTG	240;239;242	G;T;G	228;225;231	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2292	187.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1724	1726	ACC	204;205;207	A;C;C	192;196;196	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2292	187.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1778	1780	GCG	200;203;203	G;C;G	183;174;178	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2292	187.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1778	1780	GCG	200;203;203	G;C;G	183;174;178	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2292	187.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1901	1903	GGC	175;175;172	G;G;C	162;162;158	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2292	187.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1910	1912	GGC	177;178;181	G;G;C	163;162;167	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2292	187.3	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1928	1930	CTG	175;172;170	C,G;T,G;G	125,6;123,1;132	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	6044	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3099	194.4	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1637	1639	CCG	210;213;215	C;C;G	182;191;182	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2530	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1758	143.3	0	.	p	.	0	S22G	NONSYN	64	66	AGC	330	332	GGC	152;150;155	G;G;C	146;142;149	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2530	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1758	143.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	512	512	C	187	C	172	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3064	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1423	213.8	0	.	p	.	0	T18M	NONSYN	52	54	ACG	283	285	ATG	257;258;264	A;T,C;G	239;237,2;245	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3064	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1423	213.8	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	658	660	CAA	241;240;243	C;A;A	228;226;229	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3064	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1423	213.8	0	.	p	.	0	Y211H	NONSYN	631	633	TAC	862	864	CAC	269;266;264	C;A;C	255;253;254	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3064	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1423	213.8	0	.	p	.	0	E212D	NONSYN	634	636	GAA	865	867	GAT	263;259;266	G;A;T	249;250;253	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3064	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1423	213.8	0	.	p	.	0	H213D	NONSYN	637	639	CAT	868	870	GAT	261;253;252	G;A;T	249;242;239	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3064	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1423	213.8	0	.	p	.	0	V215A	NONSYN	643	645	GTT	874	876	GCT	252;254;253	G;C,A;T	243;246,1;247	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3064	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1423	213.8	0	.	p	.	0	S220T	NONSYN	658	660	AGC	889	891	ACT	258;260;264	A;C;T	239;248;248	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3064	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1423	213.8	0	.	p	.	0	R257M	NONSYN	769	771	AGG	1000	1002	ATG	249;252;256	A;T;G	232;237;240	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3064	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1423	213.8	0	.	p	.	0	R258S	NONSYN	772	774	AGG	1003	1005	AGC	255;253;254	A;G;C	240;237;241	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3064	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1423	213.8	0	.	p	.	0	A259G	NONSYN	775	777	GCT	1006	1008	GGT	253;254;257	G;G;T	241;238;240	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3064	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1423	213.8	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1120	1122	AAC	217;217;217	A;A;C	205;206;206	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3064	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1423	213.8	1	SNP	p	G120K	0	.	.	358	360	GGC	589	591	GGC	230;223;221	G;G;C	217;209;208	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11384	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4925	230.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1308	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1105	118.2	1	SNP	p	V57M	1	.	.	169	171	ATG	578	580	ATG	264;267;265	A;T;G	245;249;248	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	M177T	NONSYN	529	531	ATG	809	811	ACG	422;418;412	A;C;G	406;404;400	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	830	832	GAC	369;370;370	G,C;A;C	367,1;365;366	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	T190M	NONSYN	568	570	ACG	848	850	ATG	362;359;360	A;T;G	361;355;360	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	L194S	NONSYN	580	582	TTA	860	862	TCA	356;352;346	T;C;A	353;347;345	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	905	907	CAG	379;378;377	C,A;A;G	374,1;373;375	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	V216L	NONSYN	646	648	GTT	926	928	CTT	380;378;378	C,A;T;T	378,1;374;375	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	N223S	NONSYN	667	669	AAC	947	949	AGT	402;402;407	A;G;T	393;392;389	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1016	1018	CCG	493;495;493	C;C;G	466;467;468	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1118	1120	TCG	618;613;614	T;C;G	571;566;565	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1289	1291	AAA	294;295;292	A;A;A	287;289;286	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1292	1294	AAG	292;289;288	A;A;G	286;284;276	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1307	1309	CAC	252;253;251	C;A;C	244;240;247	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1346	1348	GAA	265;265;261	G;A;A	264;263;260	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1424	1426	ACG	177;173;174	A;C;G	177;172;174	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1475	1477	ATT	273;271;270	A;T;T	261;260;260	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1478	1480	AGT	269;267;265	A;G;T	259;257;254	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1517	1519	CTA	310;306;309	C,A;T;A	292,1;289;292	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1559	1561	AAT	202;202;201	A;A;T	195;196;196	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1628	1630	TCA	256;256;253	T;C;A	254;254;245	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1652	1654	ATG	270;269;270	A;T;G	266;264;266	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	1946	1948	ACC	591;586;592	A;C;C	552;553;553	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10862	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2498	432.1	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2042	2044	GAA	595;592;590	G;A;A	562;563;560	.	Tetracycline resistance
